Impella Versus VA-ECMO in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis With Exploratory...

Area of Science:

• Cardiology
• Critical Care Medicine
• Medical Devices

Background:

• Observational studies on Impella versus venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock yield inconsistent results.
• There is a need for updated evidence synthesis to clarify the comparative effectiveness of these mechanical circulatory support devices.

Purpose of the Study:

• To perform an updated systematic review and meta-analysis comparing Impella and VA-ECMO in adult patients with cardiogenic shock.
• To conduct exploratory matched-cohort analyses using propensity score-matched data to address confounding.

Main Methods:

• Systematic search of PubMed, Scopus, Web of Science, and Cochrane Library databases.
• Inclusion of 15 observational studies with 22,618 patients comparing Impella and VA-ECMO.
• Application of random-effects models and sensitivity analyses, including leave-one-out and propensity score-matched analyses.

Main Results:

• Crude analysis showed no significant difference in in-hospital mortality (RR 0.84, p=0.15) with high heterogeneity.
• Propensity score-matched analysis favored Impella for lower in-hospital mortality (RR 0.69, p<0.01).
• Impella was associated with lower bleeding, vascular complications, shorter ICU stay, and reduced 6-month mortality, acute kidney injury, and ischemic stroke.

Conclusions:

• While crude analysis was neutral, sensitivity and matched-cohort analyses suggest Impella may be associated with better outcomes in cardiogenic shock.
• Impella demonstrated advantages in reducing bleeding, vascular complications, and ICU length of stay.
• Findings require cautious interpretation due to observational design, risk of bias, and potential confounding.